Current Report Filing (8-k)
August 31 2020 - 9:01AM
Edgar (US Regulatory)
0001633070
false
0001633070
2020-08-28
2020-08-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): August 28, 2020
AXCELLA HEALTH INC.
(Exact name of registrant as specified in
its charter)
Delaware
|
|
001-38901
|
|
26-3321056
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
840 Memorial Drive
Cambridge, Massachusetts
|
02139
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including
area code: (857) 320-2200
Not Applicable
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction
A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section
12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
Common Stock, $0.001 Par Value
|
AXLA
|
Nasdaq Global Market
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company x
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01
|
Entry into a Material Definitive Agreement.
|
On August 28,
2020, Axcella Health Inc. (the “Company”) entered into a Third Amendment to Loan and Security Agreement (the “Loan
Amendment”) with Solar Capital Ltd., in its capacity as collateral agent and as a lender (the “Lender”). The
Loan Amendment amends the terms of that certain Loan and Security Agreement by and among the Company and the Lender, dated as of
January 9, 2018, as amended by that certain First Amendment to Loan and Security Agreement dated as of October 7, 2018, as further
amended by that certain Second Amendment to Loan and Security Agreement dated as of November 30, 2018 (as amended, the “Loan
Agreement”) to, among other things; (i) extend the date on which repayment of principal commences under the Loan Agreement
until November 2021, (ii) provide for further extensions of the date on which repayment of principal commences under the Loan Agreement
to January 2022 and May 2022, provided that certain specified regulatory and clinical milestones are satisfied by the Company,
(iii) increase the final payment fee by 1.00% to 6.35% and (iv) add a 0.20% floor to the LIBOR rate.
The above description
of the Loan Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Loan
Amendment, which is filed with this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein by reference.
Item
9.01. Financial Statements and Exhibits.
(d) Exhibits:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
AXCELLA HEALTH INC.
|
|
|
Date: August 31, 2020
|
By:
|
/s/ William R. Hinshaw, Jr.
|
|
|
|
William R. Hinshaw, Jr.
|
|
|
Chief Executive Officer, President and Director
|
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Apr 2023 to Apr 2024